dapsone has been researched along with trimethoprim sulfamethizole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lang, W; Moss, A; Osmond, D; Page-Bodkin, K; Winkelstein, W | 1 |
| Giordano, TP; Serpa, JA; Villarreal-Williams, E | 1 |
2 other study(ies) available for dapsone and trimethoprim sulfamethizole
| Article | Year |
|---|---|
Population-based estimates of antiretroviral therapy and anti-Pneumocystis prophylaxis in San Francisco: 1991.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antiviral Agents; Cohort Studies; Dapsone; Didanosine; Drug Combinations; Follow-Up Studies; HIV Infections; Humans; Male; Pentamidine; Pneumonia, Pneumocystis; San Francisco; Sulfamethizole; Trimethoprim; Zalcitabine; Zidovudine | 1993 |
Prevalence of G6PD deficiency in a large cohort of HIV-infected patients.
Topics: Adult; Aged; Anemia, Hemolytic; Anti-Infective Agents; Black or African American; Cohort Studies; Dapsone; Drug Combinations; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hispanic or Latino; HIV Infections; Humans; Male; Middle Aged; Prevalence; Sulfamethizole; Texas; Trimethoprim; Urban Population; White People; Young Adult | 2010 |